Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.171
Filter
1.
Am J Physiol Lung Cell Mol Physiol ; 327(3): L406-L414, 2024 Sep 01.
Article in English | MEDLINE | ID: mdl-39104315

ABSTRACT

Obesity is a risk factor for increased morbidity and mortality in viral respiratory infection. Mucociliary clearance (MCC) in the airway is the primary host defense against viral infections. However, the impact of obesity on MCC is unclear, prompting this study. Using murine tracheal tissue culture and in vitro influenza A virus (IAV) infection models, we analyzed cilia-driven flow and ciliary beat frequency (CBF) in the airway epithelium to evaluate MCC. Short-term IAV infection increased cilia-driven flow and CBF in control mice, but not in high-fat diet-induced obese mice. Basal cilia-driven flow and CBF were also lower in obese mice than in control mice. Mechanistically, the increase of extracellular adenosine triphosphate (ATP) release during IAV infection, which was observed in the control mice, was abolished in the obese mice; however, the addition of ATP increased cilia-driven flow and CBF both in control and obese mice to a similar extent. In addition, RNA sequencing and reverse transcription-polymerase chain reaction revealed the downregulation of several cilia-related genes, including Dnah1, Dnal1, Armc4, and Ttc12 (the dynein-related genes); Ulk4 (the polychaete differentiation gene); Cep164 (the ciliogenesis and intraflagellar transport gene); Rsph4a, Cfap206, and Ppil6 (the radial spoke structure and assembly gene); and Drc3(the nexin-dynein regulatory complex genes) in obese murine tracheal tissues compared with their control levels. In conclusion, our studies demonstrate that obesity attenuates MCC under basal conditions and during IAV infection by downregulating the expression of cilia-related genes and suppressing the release of extracellular ATP, thereby increasing the susceptibility and severity of IAV infection.NEW & NOTEWORTHY Our study shows that obesity impairs airway mucociliary clearance (MCC), an essential physical innate defense mechanism for viral infection. Mechanically, this is likely due to the obesity-induced downregulation of cilia-related genes and attenuation of extracellular ATP release. This study provides novel insights into the mechanisms driving the higher susceptibility and severity of viral respiratory infections in individuals with obesity.


Subject(s)
Cilia , Mucociliary Clearance , Obesity , Respiratory Mucosa , Animals , Cilia/metabolism , Cilia/pathology , Obesity/metabolism , Obesity/pathology , Obesity/physiopathology , Obesity/complications , Mice , Respiratory Mucosa/metabolism , Respiratory Mucosa/pathology , Respiratory Mucosa/virology , Mice, Inbred C57BL , Adenosine Triphosphate/metabolism , Male , Trachea/metabolism , Trachea/virology , Trachea/pathology , Influenza A virus , Orthomyxoviridae Infections/virology , Orthomyxoviridae Infections/pathology , Orthomyxoviridae Infections/metabolism , Diet, High-Fat/adverse effects
2.
In Vivo ; 38(5): 2294-2299, 2024.
Article in English | MEDLINE | ID: mdl-39187341

ABSTRACT

BACKGROUND/AIM: Cigarette smoke has been shown to induce a phenotype in humans known as "acquired cystic fibrosis". This occurs because the cystic fibrosis transmembrane conductance regulator (CFTR) functions are impaired systemically due to the deleterious effects of smoke components. Elucidation of cigarette smoke effects on the tracheal epithelium is important. The aim of this study was to develop an ex vivo sheep tracheal model to investigate tracheal ion function. In this model, the epithelial sodium channel (ENaC) is inhibited after exposure to cigarette smoke extract (CSE) as a proof of principle. MATERIALS AND METHODS: Tracheas were isolated from healthy sheep and the tracheal epithelium was surgically excised. Tissues were mounted in Ussing chambers and the short circuit current (Isc) was measured after incubation with 5% CSE in PBS or PBS alone for 30 min. The function of ENaC was investigated by the addition of amiloride (10-5M) apically. Western blot analysis was performed to assess differences in ENaC quantity after CSE exposure. Some specimens were stained with H&E for detection of histological alterations. RESULTS: The amiloride effect on normal epithelium led to a significant decrease in Isc [ΔI=33±5.92 µA/cm2; p<0.001 versus control experiments (ΔI=1.44±0.71 µA/cm2)]. After incubation with CSE, ENaC Isc was significantly reduced (ΔI=14.80±1.96 µA/cm2; p<0.001). No differences in αENaC expression were observed between CSE-exposed and normal tracheal epithelium. Histological images post CSE incubation revealed decreases in the height of the epithelium, with basal cell hyperplasia and loss of ciliated cells. CONCLUSION: Reduced ENaC inhibition by amiloride after CSE incubation could be due to alterations in the tracheal epithelium.


Subject(s)
Epithelial Sodium Channels , Trachea , Animals , Epithelial Sodium Channels/metabolism , Sheep , Trachea/metabolism , Trachea/drug effects , Trachea/pathology , Pilot Projects , Smoke/adverse effects , Amiloride/pharmacology , Respiratory Mucosa/metabolism , Respiratory Mucosa/drug effects , Respiratory Mucosa/pathology , Epithelium/drug effects , Epithelium/metabolism , Epithelium/pathology
3.
BMJ Case Rep ; 17(8)2024 Aug 19.
Article in English | MEDLINE | ID: mdl-39159986

ABSTRACT

A woman in her early 30s presented to her primary care physician's office with hoarseness, joint pain and facial swelling. The objective evaluation revealed elevated inflammatory markers and angiotensin-1-converting enzyme, a chest radiograph with bilateral hilar prominence and a maxillofacial CT scan with diffuse inflammation in the upper airway. Otolaryngology evaluation revealed exophytic lesions diffusely within the nasal cavity, base of tongue, supraglottis, glottis and trachea. A biopsy confirmed the diagnosis of sarcoidosis. She was treated with corticosteroids with improvement in upper and lower airway symptoms. She continued to experience other extrapulmonary manifestations of sarcoidosis requiring alternative immunosuppressant therapy. At 30 months from symptom onset, her disease was noted to be in remission.


Subject(s)
Laryngeal Diseases , Sarcoidosis , Tracheal Diseases , Humans , Female , Sarcoidosis/diagnosis , Sarcoidosis/drug therapy , Sarcoidosis/pathology , Laryngeal Diseases/drug therapy , Laryngeal Diseases/diagnosis , Laryngeal Diseases/pathology , Laryngeal Diseases/diagnostic imaging , Adult , Tracheal Diseases/diagnosis , Tracheal Diseases/diagnostic imaging , Tracheal Diseases/pathology , Tomography, X-Ray Computed , Trachea/pathology , Trachea/diagnostic imaging
4.
J Vis Exp ; (210)2024 Aug 02.
Article in English | MEDLINE | ID: mdl-39158297

ABSTRACT

Chronic cough, which lasts for more than 8 weeks, is one of the most common complaints requiring medical attention, and patients suffer from a huge socioeconomic burden and a marked decrement in quality of life. Animal models can mimic the complex pathophysiology of the cough and are important tools for cough research. The detection of cough sensitivity and airway inflammation is of great significance for studying the complex pathological mechanism of cough. This article describes the measurement of cough using a noninvasive and real-time whole-body plethysmography (WBP) system and the normative procedures for harvesting tissue samples (including blood, lung, spleen, and trachea) of mice. It introduces some methods to assess airway inflammation, including pathological changes in hematoxylin and eosin (HE)-stained lung and trachea sections, the total protein concentration, the uric acid concentration, and the lactate dehydrogenase (LDH) activity in the supernatant of bronchoalveolar lavage fluid (BALF), and the leukocytes and differential cell counts of BALF. These methods are reproducible and serve as valuable tools to study the complex pathophysiology of cough.


Subject(s)
Bronchoalveolar Lavage Fluid , Cough , Plethysmography, Whole Body , Animals , Mice , Bronchoalveolar Lavage Fluid/chemistry , Bronchoalveolar Lavage Fluid/cytology , Plethysmography, Whole Body/methods , Disease Models, Animal , Lung/pathology , Inflammation/pathology , Trachea/pathology
5.
Eur J Cardiothorac Surg ; 66(2)2024 Aug 02.
Article in English | MEDLINE | ID: mdl-38980196

ABSTRACT

OBJECTIVES: Our objective was to explore the safety and efficacy of a graphene oxide-loaded rapamycin-coated self-expandable metallic airway stent (GO@RAPA-SEMS) in a rabbit model. METHODS: The dip coating method was used to develop a GO@RAPA-SEMS and a poly(lactic-co-glycolic)-acid loaded rapamycin-coated self-expandable metallic airway stent (PLGA@RAPA-SEMS). The surface structure was evaluated using a scanning electronic microscope. The in vitro drug-release profiles of the 2 stents were explored and compared. In the animal study, a total of 45 rabbits were randomly divided into 3 groups and underwent 3 kinds of stent placements. Computed tomography was performed to evaluate the degree of stenosis at 1, 2 and 3 months after the stent operation. Five rabbits in each group were sacrificed after the computed tomography scan. The stented trachea and blood were collected for further pathological analysis and laboratory testing. RESULTS: The in vitro drug-release study revealed that GO@RAPA-SEMS exhibited a sudden release on the first day and maintained a certain release rate on the 14th day. The PLGA@RAPA-SEMS exhibited a longer sustained release time. All 45 rabbits underwent successful stent placement. Pathological results indicated that the granulation tissue thickness in the GO@RAPA-SEMS group was less than that in the PLGA@RAPA-SEMS group. The TUNEL and hypoxia-inducible factor-1α staining results support the fact that the granulation inhibition effect in the GO@RAPA-SEMS group was greater than that in the PLGA@RAPA-SEMS group. CONCLUSIONS: GO@RAPA-SEMS effectively inhibited stent-related granulation tissue hyperplasia.


Subject(s)
Drug-Eluting Stents , Granulation Tissue , Graphite , Sirolimus , Animals , Rabbits , Graphite/administration & dosage , Sirolimus/administration & dosage , Sirolimus/pharmacology , Granulation Tissue/drug effects , Granulation Tissue/pathology , Hyperplasia/prevention & control , Self Expandable Metallic Stents , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Coated Materials, Biocompatible , Disease Models, Animal , Trachea/drug effects , Trachea/pathology
6.
Sci Rep ; 14(1): 16567, 2024 07 17.
Article in English | MEDLINE | ID: mdl-39019933

ABSTRACT

Serine proteases are important regulators of airway epithelial homeostasis. Altered serum or cellular levels of two serpins, Scca1 and Spink5, have been described for airway diseases but their function beyond antiproteolytic activity is insufficiently understood. To close this gap, we generated fly lines with overexpression or knockdown for each gene in the airways. Overexpression of both fly homologues of Scca1 and Spink5 induced the growth of additional airway branches, with more variable results for the respective knockdowns. Dysregulation of Scca1 resulted in a general delay in fruit fly development, with increases in larval and pupal mortality following overexpression of this gene. In addition, the morphological changes in the airways were concomitant with lower tolerance to hypoxia. In conclusion, the observed structural changes of the airways evidently had a strong impact on the airway function in our model as they manifested in a lower physical fitness of the animals. We assume that this is due to insufficient tissue oxygenation. Future work will be directed at the identification of key molecular regulators following the airway-specific dysregulation of Scca1 and Spink5 expression.


Subject(s)
Asthma , Drosophila melanogaster , Serpins , Trachea , Animals , Drosophila melanogaster/metabolism , Drosophila melanogaster/genetics , Trachea/metabolism , Trachea/pathology , Asthma/metabolism , Asthma/pathology , Asthma/genetics , Serpins/metabolism , Serpins/genetics , Drosophila Proteins/metabolism , Drosophila Proteins/genetics , Oxygen/metabolism
7.
J Appl Biomed ; 22(2): 115-122, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38912867

ABSTRACT

In 2020, there were numerous cases in Kazakhstan with clinical symptoms of COVID-19 but negative PCR results in nasopharyngeal and oropharyngeal swabs. The diagnosis was confirmed clinically and by CT scans (computed tomography). The problem with such negative PCR results for SARS-CoV-2 infection confirmation still exists and indicates the need to confirm the diagnosis in the bronchoalveolar lavage in such cases. There is also a lack of information about confirmation of SARS-CoV-2 infection in deceased patients. In this study, various tissue materials, including lungs, bronchi, and trachea, were examined from eight patients who died, presumably from SARS-CoV-2 infection, between 2020 and 2022. Naso/oropharyngeal swabs taken from these patients in hospitals tested PCR negative for SARS-CoV-2. This study presents a modified RNA isolation method based on a comparison of the most used methods for RNA isolation in laboratories: QIAamp Viral RNA Mini Kit and TRIzol-based method. This modified nucleic acid extraction protocol can be used to confirm SARS-CoV-2 infection by RT-qPCR in the tissues of deceased patients in disputed cases. RT-qPCR with RNA of SARS-CoV-2 re-extracted with such method from post-mortem tissues that were stored at -80 °C for more than 32 months still demonstrated high-yielding positive results.


Subject(s)
Autopsy , COVID-19 , RNA, Viral , SARS-CoV-2 , Humans , COVID-19/virology , COVID-19/diagnosis , COVID-19/genetics , SARS-CoV-2/genetics , RNA, Viral/genetics , RNA, Viral/analysis , Male , Autopsy/methods , Real-Time Polymerase Chain Reaction/methods , Female , Lung/virology , Lung/pathology , Lung/diagnostic imaging , Middle Aged , Aged , COVID-19 Nucleic Acid Testing/methods , Trachea/virology , Trachea/pathology , Trachea/diagnostic imaging , Adult , Nasopharynx/virology
8.
World J Gastroenterol ; 30(16): 2272-2280, 2024 Apr 28.
Article in English | MEDLINE | ID: mdl-38690021

ABSTRACT

BACKGROUND: The magnetic compression technique has been used to establish an animal model of tracheoesophageal fistula (TEF), but the commonly shaped magnets present limitations of poor homogeneity of TEF and poor model control. We designed a T-shaped magnet system to overcome these problems and verified its effectiveness via animal experiments. AIM: To investigate the effectiveness of a T-shaped magnet system for establishing a TEF model in beagle dogs. METHODS: Twelve beagles were randomly assigned to groups in which magnets of the T-shaped scheme (study group, n = 6) or normal magnets (control group, n = 6) were implanted into the trachea and esophagus separately under gastroscopy. Operation time, operation success rate, and accidental injury were recorded. After operation, the presence and timing of cough and the time of magnet shedding were observed. Dogs in the control group were euthanized after X-ray and gastroscopy to confirm establishment of TEFs after coughing, and gross specimens of TEFs were obtained. Dogs in the study group were euthanized after X-ray and gastroscopy 2 wk after surgery, and gross specimens were obtained. Fistula size was measured in all animals, and then harvested fistula specimens were examined by hematoxylin and eosin (HE) and Masson trichrome staining. RESULTS: The operation success rate was 100% for both groups. Operation time did not differ between the study group (5.25 min ± 1.29 min) and the control group (4.75 min ± 1.70 min; P = 0.331). No bleeding, perforation, or unplanned magnet attraction occurred in any animal during the operation. In the early postoperative period, all dogs ate freely and were generally in good condition. Dogs in the control group had severe cough after drinking water at 6-9 d after surgery. X-ray indicated that the magnets had entered the stomach, and gastroscopy showed TEF formation. Gross specimens of TEFs from the control group showed the formation of fistulas with a diameter of 4.94 mm ± 1.29 mm (range, 3.52-6.56 mm). HE and Masson trichrome staining showed scar tissue formation and hierarchical structural disorder at the fistulas. Dogs in the study group did not exhibit obvious coughing after surgery. X-ray examination 2 wk after surgery indicated fixed magnet positioning, and gastroscopy showed no change in magnet positioning. The magnets were removed using a snare under endoscopy, and TEF was observed. Gross specimens showed well-formed fistulas with a diameter of 6.11 mm ± 0.16 mm (range, 5.92-6.36 mm), which exceeded that in the control group (P < 0.001). Scar formation was observed on the internal surface of fistulas by HE and Masson trichrome staining, and the structure was more regular than that in the control group. CONCLUSION: Use of the modified T-shaped magnet scheme is safe and feasible for establishing TEF and can achieve a more stable and uniform fistula size compared with ordinary magnets. Most importantly, this model offers better controllability, which improves the flexibility of follow-up studies.


Subject(s)
Disease Models, Animal , Magnets , Trachea , Tracheoesophageal Fistula , Animals , Dogs , Tracheoesophageal Fistula/surgery , Tracheoesophageal Fistula/pathology , Tracheoesophageal Fistula/etiology , Trachea/surgery , Trachea/pathology , Esophagus/surgery , Esophagus/pathology , Esophagus/diagnostic imaging , Gastroscopy/instrumentation , Gastroscopy/methods , Operative Time , Male , Magnetics/instrumentation , Equipment Design , Humans
9.
Eur J Surg Oncol ; 50(7): 108390, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38723412

ABSTRACT

INTRODUCTION: The surgical management of patients diagnosed with papillary thyroid carcinoma (PTC) and tracheal invasion has been a subject of ongoing discussion, particularly regarding the approach to tracheal functional reconstruction. The objective of this study was to examine the surgical technique and prognosis of PTC patients with tracheal invasion. MATERIALS AND METHODS: This study employed both univariate and multivariate Cox proportional hazard models to determine predictive factors that affect the progression-free survival (PFS) of PTC patients with tracheal invasion. Cox regression analysis was conducted by using R software version 4.3.1. RESULTS: In our study, we included 247 patients with T4a PTC. Among them, 146 patients (59.1 %) were classified as Shin I, 57 patients (23.1 %) as Shin II-III, and 44 patients (17.8 %) as Shin IV. Patients in the Shin I group underwent shaving of the tumours in the airway. The preferred surgical methods in the Shin II, III and IV groups were window resection (66.7 %), sleeve resection (34.8 %) and partial tracheal resection and skin fistula (61.8 %), respectively. Multivariate analysis demonstrated that neither tracheal surgery nor reconstruction procedures had an impact on PFS in T4a PTC patients with tracheal invasion. The 5-year DSS rate for patients receiving radioiodine (RAI) therapy was 87.3 % (p = 0.033). CONCLUSION: This study confirmed that tracheal surgery and reconstruction methods had no impact on PFS in T4a PTC patients with tracheal invasion in different Shin groups. Furthermore, RAI therapy has the potential to increase the survival rate of patients with preoperative distant metastasis of T4a PTC.


Subject(s)
Neoplasm Invasiveness , Plastic Surgery Procedures , Thyroid Cancer, Papillary , Thyroid Neoplasms , Humans , Male , Female , Thyroid Cancer, Papillary/surgery , Thyroid Cancer, Papillary/pathology , Middle Aged , Thyroid Neoplasms/surgery , Thyroid Neoplasms/pathology , Adult , Plastic Surgery Procedures/methods , Thyroidectomy/methods , Tracheal Neoplasms/surgery , Tracheal Neoplasms/pathology , Retrospective Studies , Aged , Trachea/surgery , Trachea/pathology , Proportional Hazards Models , Progression-Free Survival , Prognosis , Neoplasm Staging
10.
Biochim Biophys Acta Mol Basis Dis ; 1870(6): 167216, 2024 08.
Article in English | MEDLINE | ID: mdl-38718843

ABSTRACT

Studies have highlighted an upregulation of PD-1 expression in CD4+ T cells, which accelerates lung fibrosis by activating the IL-17/STAT3 pathway, leading to IL-17A and TGF-ß1 secretion. However, the relation with traumatic tracheal stenosis (TS) remains unexplored. Our analysis found significant increases in PD-1+CD4+ T cells, IL-17A, and TGF-ß1 in the TS patients (n = 10). The cellular model used CD4+ T cells co-cultured with bronchial fibroblasts while the animal model used a nylon brush to scrape the damaged tracheal mucosa. Interventions with PD-1 and STAT3 inhibitors both in vitro (n = 5) and in vivo (n = 6) showed decreased expression of TGF-ß1 and IL-17A in CD4+ T cells, decreased collagen I synthesis in vitro, and reduced tractal fibrosis in vivo. Furthermore, PD-1's modulation of the STAT3 was evident. This research unveils PD-1+CD4+ T cells' role in TS, thus suggesting a novel immunotherapeutic strategy to counteract tracheal fibrosis.


Subject(s)
CD4-Positive T-Lymphocytes , Interleukin-17 , Programmed Cell Death 1 Receptor , STAT3 Transcription Factor , Signal Transduction , Tracheal Stenosis , STAT3 Transcription Factor/metabolism , Programmed Cell Death 1 Receptor/metabolism , Programmed Cell Death 1 Receptor/genetics , Interleukin-17/metabolism , Interleukin-17/immunology , Humans , Animals , CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/metabolism , Tracheal Stenosis/pathology , Tracheal Stenosis/metabolism , Tracheal Stenosis/immunology , Male , Female , Adult , Middle Aged , Transforming Growth Factor beta1/metabolism , Mice , Fibrosis , Disease Models, Animal , Trachea/pathology , Trachea/metabolism , Trachea/immunology
11.
Rev Mal Respir ; 41(6): 421-438, 2024 Jun.
Article in French | MEDLINE | ID: mdl-38762394

ABSTRACT

Relapsing polychondritis is a systemic auto-immune disease that mainly affects cartilage structures, progressing through inflammatory flare-ups between phases of remission and ultimately leading to deformation of the cartilages involved. In addition to characteristic damage of auricular or nasal cartilage, tracheobronchial and cardiac involvement are particularly severe, and can seriously alter the prognosis. Tracheobronchial lesions are assessed by means of a multimodal approach, including dynamic thoracic imaging, measurement of pulmonary function (with recent emphasis on pulse oscillometry), and mapping of tracheal lesions through flexible bronchoscopy. Diagnosis can be difficult in the absence of specific diagnostic tools, especially as there may exist a large number of differential diagnoses, particularly as regards inflammatory diseases. The prognosis has improved, due largely to upgraded interventional bronchoscopy techniques and the development of immunosuppressant drugs and targeted therapies, offering patients a number of treatment options.


Subject(s)
Bronchial Diseases , Polychondritis, Relapsing , Polychondritis, Relapsing/diagnosis , Polychondritis, Relapsing/complications , Humans , Diagnosis, Differential , Bronchial Diseases/diagnosis , Bronchial Diseases/pathology , Bronchial Diseases/etiology , Tracheal Diseases/diagnosis , Tracheal Diseases/pathology , Bronchoscopy/methods , Trachea/pathology , Bronchi/pathology
13.
J Pharmacol Sci ; 155(2): 21-28, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38677782

ABSTRACT

Goblet cell hyperplasia and increased mucus production are features of airway diseases, including asthma, and excess airway mucus often worsens these conditions. Even steroids are not uniformly effective in mucus production in severe asthma, and new therapeutic options are needed. Seihaito is a Japanese traditional medicine that is used clinically as an antitussive and expectorant. In the present study, we examined the effect of Seihaito on goblet cell differentiation and mucus production. In in vitro studies, using air-liquid interface culture of guinea-pig tracheal epithelial cells, Seihaito inhibited IL-13-induced proliferation of goblet cells and MUC5AC, a major component of mucus production. Seihaito suppressed goblet cell-specific gene expression, without changing ciliary cell-specific genes, suggesting that it inhibits goblet cell differentiation. In addition, Seihaito suppressed MUC5AC expression in cells transfected with SPDEF, a transcription factor activated by IL-13. Furthermore, Seihaito attenuated in vivo goblet cell proliferation and MUC5AC mRNA expression in IL-13-treated mouse lungs. Collectively, these findings demonstrated that Seihaito has an inhibitory effect on goblet cell differentiation and mucus production, which is at least partly due to the inhibition of SPDEF.


Subject(s)
Cell Differentiation , Cell Proliferation , Goblet Cells , Interleukin-13 , Medicine, Kampo , Metaplasia , Mucin 5AC , Mucus , Animals , Goblet Cells/drug effects , Goblet Cells/pathology , Goblet Cells/metabolism , Interleukin-13/metabolism , Mucin 5AC/genetics , Mucin 5AC/metabolism , Mucus/metabolism , Cell Differentiation/drug effects , Guinea Pigs , Cell Proliferation/drug effects , Drugs, Chinese Herbal/pharmacology , Cells, Cultured , Proto-Oncogene Proteins c-ets/genetics , Proto-Oncogene Proteins c-ets/metabolism , Male , Gene Expression/drug effects , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Mice , Trachea/cytology , Trachea/drug effects , Trachea/pathology , Trachea/metabolism
14.
Zhonghua Jie He He Hu Xi Za Zhi ; 47(4): 346-351, 2024 Apr 12.
Article in Chinese | MEDLINE | ID: mdl-38599810

ABSTRACT

A 58-year-old woman presented with a six-month history of nasal congestion, sore throat and cough, and a five-month history of dyspnea. She had a history of xerostomia for one year. On examination, the bilateral submandibular gland and parotid glands were enlarged. Parotid and anterior cervical lymph nodes were palpable. There were rales in both lungs. The rest of the physical examination was unremarkable. Sialographic analysis showed normal caliber in the main duct, stenosis in secondary ducts, and dilation in the proximal ducts. Minor salivary gland biopsy demonstrated periductal lymphocytic infiltration. Chest computed tomography (CT) showed diffuse thickening of the tracheal and bilateral bronchial walls. Bronchoscopy revealed macroscopic multiple nodules mainly in the trachea and bilateral main bronchus. Endobronchial biopsy showed lymphocytic infiltration in the bronchial submucosa. She was diagnosed with Sjögren's syndrome and treated with glucocorticoids. The dose of prednisone was started at 30 mg/d and tapered gradually. Following treatment, the patient's clinical condition improved dramatically, with shrinkage of the enlarged lymph nodes, bilateral submandibular and parotid glands. A repeated chest CT scan revealed improvement of the tracheal and bilateral bronchial thickening. Multiple nodules in the airway regressed, as evidenced by repeated bronchoscopic examination. The final diagnosis was a large-airway disease associated with Sjögren's syndrome.Among airway diseases in Sjögren's syndrome, peripheral airway diseases including bronchiolitis and bronchiectasis are common; however, central airway lesions in Sjögren's syndrome, especially with macroscopic nodules, are rare. In this case, we demonstrated tracheal and endobronchial nodules in Sjögren's syndrome as determined by clinical features, CT scan, bronchoscopy, and response to therapy.


Subject(s)
Sjogren's Syndrome , Female , Humans , Middle Aged , Sjogren's Syndrome/complications , Sjogren's Syndrome/diagnosis , Sjogren's Syndrome/pathology , Trachea/pathology , Parotid Gland/pathology , Lung/pathology , Bronchi/pathology
15.
BMJ Case Rep ; 17(4)2024 Apr 09.
Article in English | MEDLINE | ID: mdl-38594197

ABSTRACT

Primary tracheal schwannomas are rare benign tumours. This is a case report, and therefore, no specific methods or results are applicable. We here report a case of a tracheal schwannoma in an early adolescent girl presenting with subcutaneous emphysema and symptoms of airway obstruction. Tracheal resection and reconstruction by primary anastomosis were performed. Pathology confirmed the diagnosis of tracheal schwannoma. This is an unusual life-threatening presentation of a benign rare tracheal tumour with a challenging approach to management.


Subject(s)
Mediastinal Emphysema , Neurilemmoma , Subcutaneous Emphysema , Tracheal Neoplasms , Female , Humans , Adolescent , Mediastinal Emphysema/diagnostic imaging , Mediastinal Emphysema/etiology , Mediastinal Emphysema/surgery , Trachea/diagnostic imaging , Trachea/surgery , Trachea/pathology , Tracheal Neoplasms/diagnosis , Tracheal Neoplasms/diagnostic imaging , Neurilemmoma/diagnosis , Neurilemmoma/diagnostic imaging , Subcutaneous Emphysema/diagnostic imaging , Subcutaneous Emphysema/etiology
16.
Am J Med Genet A ; 194(9): e63587, 2024 09.
Article in English | MEDLINE | ID: mdl-38687163

ABSTRACT

Genital anomalies have been reported with VACTERL association but not considered a core feature. Acute and chronic complications stemming from unrecognized genital anomalies have been reported in adolescents and young adults with VACTERL association. We sought to determine the frequency and severity of genital anomalies in VACTERL patients and identify which core features were more frequently associated with genital anomalies. A retrospective chart review from January 2010 to October 2021 identified 211 patients with two or more core VACTERL features, 34% of whom had a genital anomaly. The majority of genital anomalies (83% of those in males and 90% in females) were classified as functionally significant (requiring surgical intervention or causing functional impairment). The frequency of genital anomalies in the VACTERL cohort was higher if anorectal malformations or renal anomalies were present in both males and females and if vertebral anomalies were present in females. Due to their functional significance, genital anomalies should be assessed in all patients with two or more core features of VACTERL association, especially in those with anorectal or renal anomalies. Most genital anomalies in males will be detected on physical examination but additional investigation is often needed to detect genital anomalies in females. The timing and type of investigation are subjects for future study.


Subject(s)
Anal Canal , Esophagus , Heart Defects, Congenital , Kidney , Limb Deformities, Congenital , Spine , Trachea , Humans , Male , Female , Anal Canal/abnormalities , Anal Canal/pathology , Limb Deformities, Congenital/pathology , Limb Deformities, Congenital/genetics , Limb Deformities, Congenital/diagnosis , Limb Deformities, Congenital/epidemiology , Esophagus/abnormalities , Esophagus/pathology , Spine/abnormalities , Spine/pathology , Trachea/abnormalities , Trachea/pathology , Adolescent , Heart Defects, Congenital/pathology , Heart Defects, Congenital/epidemiology , Heart Defects, Congenital/genetics , Heart Defects, Congenital/diagnosis , Kidney/abnormalities , Kidney/pathology , Adult , Retrospective Studies , Child , Young Adult , Child, Preschool , Urogenital Abnormalities/epidemiology , Urogenital Abnormalities/genetics , Urogenital Abnormalities/diagnosis , Urogenital Abnormalities/pathology , Infant , Anorectal Malformations/epidemiology , Anorectal Malformations/genetics , Anorectal Malformations/diagnosis , Anorectal Malformations/pathology , Genitalia/abnormalities , Genitalia/pathology
17.
BMJ Case Rep ; 17(3)2024 Mar 07.
Article in English | MEDLINE | ID: mdl-38453228

ABSTRACT

Encountering and managing an unanticipated difficult airway are among the many challenges faced by anaesthesiologists. Due to the intimate anatomical relationship between the thoracic vasculature and the trachea, an anatomical variation could potentially lead to airway compression. This clinical case report documents a failed intubation in an adult patient caused by undiagnosed extrinsic tracheal compression from the brachiocephalic arterial trunk, a rare condition. After a thorough investigation and diagnostic clarification, a safe anaesthetic plan following the predictable difficult airway guidelines was established to enable surgery. Anaesthesiologists should consider rare vascular causes as potential contributors to difficult airway scenarios, thereby enhancing their expertise.


Subject(s)
Intubation, Intratracheal , Trachea , Adult , Humans , Aorta , Brachiocephalic Trunk , Trachea/pathology
18.
Thorac Cancer ; 15(11): 878-883, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38429910

ABSTRACT

BACKGROUND: Primary tracheal tumors are very rare and the literature on this subject is limited. The most common histological type of primary tracheal tumors is squamous cell carcinoma (SCC), followed by adenoid cystic carcinoma (ACC). Limited knowledge exists regarding the behavior and outcomes of different histological types of tracheal cancers. The present study aimed to address this gap by assessing the significance of the histological type of primary tracheal tumors based on our own data and to review the literature. METHODS: We carried out a retrospective analysis of 89 patients with primary tracheal tumors treated at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, between 2000 and 2016. The study assessed patient demographics, tumor characteristics and treatment, with a focus on SCC, ACC, and other histological types. Different histological types were compared in terms of overall survival, disease-free survival, and progression-free survival. RESULTS: SCC was the most frequently diagnosed histological type (56.2%), followed by ACC (21.3%). Patients with SCC were typically older (78% over 60 years), predominantly male (66%), and associated with smoking. In contrast, the ACC had a more balanced gender distribution and did not correlate with smoking. ACC displayed a significantly better prognosis, with a median overall survival of 129.4 months, compared with 9.0 months for SCC. CONCLUSION: Histological type plays a crucial role in the prognosis of primary tracheal tumors. ACC demonstrated a more favorable outcome compared with SCC.


Subject(s)
Carcinoma, Adenoid Cystic , Carcinoma, Squamous Cell , Tracheal Neoplasms , Humans , Male , Female , Tracheal Neoplasms/pathology , Retrospective Studies , Trachea/pathology , Prognosis , Disease-Free Survival , Carcinoma, Squamous Cell/pathology
19.
Virol Sin ; 39(2): 309-318, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38458399

ABSTRACT

SARS-CoV-2 infection-induced hyper-inflammation is a key pathogenic factor of COVID-19. Our research, along with others', has demonstrated that mast cells (MCs) play a vital role in the initiation of hyper-inflammation caused by SARS-CoV-2. In previous study, we observed that SARS-CoV-2 infection induced the accumulation of MCs in the peri-bronchus and bronchioalveolar-duct junction in humanized mice. Additionally, we found that MC degranulation triggered by the spike protein resulted in inflammation in alveolar epithelial cells and capillary endothelial cells, leading to subsequent lung injury. The trachea and bronchus are the routes for SARS-CoV-2 transmission after virus inhalation, and inflammation in these regions could promote viral spread. MCs are widely distributed throughout the respiratory tract. Thus, in this study, we investigated the role of MCs and their degranulation in the development of inflammation in tracheal-bronchial epithelium. Histological analyses showed the accumulation and degranulation of MCs in the peri-trachea of humanized mice infected with SARS-CoV-2. MC degranulation caused lesions in trachea, and the formation of papillary hyperplasia was observed. Through transcriptome analysis in bronchial epithelial cells, we found that MC degranulation significantly altered multiple cellular signaling, particularly, leading to upregulated immune responses and inflammation. The administration of ebastine or loratadine effectively suppressed the induction of inflammatory factors in bronchial epithelial cells and alleviated tracheal injury in mice. Taken together, our findings confirm the essential role of MC degranulation in SARS-CoV-2-induced hyper-inflammation and the subsequent tissue lesions. Furthermore, our results support the use of ebastine or loratadine to inhibit SARS-CoV-2-triggered degranulation, thereby preventing tissue damage caused by hyper-inflammation.


Subject(s)
Bronchi , COVID-19 , Cell Degranulation , Mast Cells , SARS-CoV-2 , Trachea , Animals , Mast Cells/virology , Mast Cells/immunology , COVID-19/immunology , COVID-19/virology , COVID-19/pathology , Mice , Trachea/virology , Trachea/pathology , Bronchi/virology , Bronchi/pathology , Humans , Inflammation/virology , Epithelial Cells/virology , Disease Models, Animal
20.
Acta Cir Bras ; 39: e390324, 2024.
Article in English | MEDLINE | ID: mdl-38324799

ABSTRACT

PURPOSE: The current study aimed at evaluating the repair of a partial defect of the trachea with a muscle flap, an advanced technique that employs combined suture patterns. METHODS: Sixteen healthy male New Zealand white rabbits were used as an experimental model. A partial defect in the trachea within the ventral region of the fourth to eighth tracheal ring was created. Subsequently, repair was initiated with a flap of the sternocephalicus muscle. The animals were divided into four groups for postoperative evaluation using clinical, tracheoscopic, and histopathological analyses. Each group was separated according to the time of euthanasia, programmed at interval of seven (G7), 15 (G15), 30 (G30), and 60 days (G60). RESULTS: One animal from the G60 group died, whereas the other animals had good surgical recovery without serious changes in the breathing pattern. The major clinical signs observed were stridor and coughing. Tracheoscopy revealed secretions in the tracheal lumen, exuberant granulation, and stenosis. Histopathological analysis showed growth of the ciliary respiratory epithelium at the flap site 30 days after implantation. CONCLUSIONS: Partial repair showed satisfactory results owing to the anatomical location of the muscle, adequate vascular support, and structural and physiological maintenance without serious changes in the respiratory system.


Subject(s)
Plastic Surgery Procedures , Trachea , Rabbits , Male , Animals , Trachea/surgery , Trachea/pathology , Surgical Flaps/surgery , Muscles/surgery
SELECTION OF CITATIONS
SEARCH DETAIL